




Searching News Database: atorvastatin
HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
HSMN NewsFeed - 18 Sep 2008
Dr. Michael Beckert Steps Down as EVP and CMO of LifeCycle Pharma Effective December 31, 2008
Dr. Michael Beckert Steps Down as EVP and CMO of LifeCycle Pharma Effective December 31, 2008
HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
HSMN NewsFeed - 5 May 2008
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
HSMN NewsFeed - 21 Apr 2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
HSMN NewsFeed - 25 Jan 2008
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
HSMN NewsFeed - 14 Jan 2008
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
HSMN NewsFeed - 12 Jul 2007
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
HSMN NewsFeed - 27 Mar 2007
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
HSMN NewsFeed - 26 Mar 2007
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
HSMN NewsFeed - 26 Mar 2007
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
HSMN NewsFeed - 7 Mar 2007
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
HSMN NewsFeed - 23 Feb 2007
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed - 26 Jan 2007
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
HSMN NewsFeed - 20 Dec 2006
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
HSMN NewsFeed - 4 Dec 2006
Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs
Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs
HSMN NewsFeed - 13 Nov 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
HSMN NewsFeed - 23 Oct 2006
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
HSMN NewsFeed - 17 Oct 2006
Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor Patent
Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor Patent
HSMN NewsFeed - 9 Aug 2006
Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
HSMN NewsFeed - 25 Apr 2006
Pfizer Says Austrian Court Ruling on Lipitor Enantiomer Patent Has No Effect on Cases in Other Jurisdictions
Pfizer Says Austrian Court Ruling on Lipitor Enantiomer Patent Has No Effect on Cases in Other Jurisdictions
HSMN NewsFeed - 11 Apr 2006
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
HSMN NewsFeed - 14 Mar 2006
New Torcetrapib/Atorvastatin Research Further Supports Raising 'Good' HDL Cholesterol
New Torcetrapib/Atorvastatin Research Further Supports Raising 'Good' HDL Cholesterol
HSMN NewsFeed - 6 Feb 2006
Roche to Focus Resources on Availability of INVIRASE(R), Now Preferred Formulation of Saquinavir
Roche to Focus Resources on Availability of INVIRASE(R), Now Preferred Formulation of Saquinavir
Additional items found! 55

Members Archive contains
55 additional stories matching:
atorvastatin
(Password required)
atorvastatin
(Password required)